PRELOAD PRELOAD PRELOAD PRELOAD PRELOAD

Products

Products

BioMarin has developed and commercialized five products since 1997, a remarkable accomplishment in the biopharmaceutical industry, and a testament to the company’s passion and dedication to patients with serious, unmet medical needs.

Products on the Market

BioMarin has five marketed products on the market today:
  • VIMIZIM (elosulfase alfa) for Morquio A syndrome (MPS IVA)
  • Kuvan® (sapropterin dihydrochloride) Tablets for PKU
  • Naglazyme® (galsulfase) for MPS VI
  • Aldurazyme® (laronidase) for MPS I
  • Firdapse®(currently approved in the EU only) (amifampridine phosphate) for LEMS

For full prescribing information, please visit www.VIMIZIM.com, www.kuvan.com, www.naglazyme.com, and www.aldurazyme.com.